Secteur Spero Therapeutics, Inc.

Actions

SPRO

US84833T1034

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX 18:57:46 28/07/2026 Varia. 5j. Varia. 1 janv.
1,245 USD +5,51% Graphique intraday de Spero Therapeutics, Inc. -12,95% -48,44%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
+5,51%-12,95%-46,85%-55,01%-48,44%-47,77%-15,40%-91,55% - 68,32 M
-2,25%+1,55%-1,71%+15,99%+7,70%+50,84%+70,04%+200,86%+5 907,78% 56,19 Md
-1,32%-0,97%+4,10%+22,38%+35,72%+38,41%+77,52%-14,92% - 54,83 Md
+1,21%-0,67%-2,71%-10,14%-3,67%-18,69%-14,62%-70,74% - 23,04 Md
+0,16%-3,82%-0,26%-22,58%-39,97%+2,67%+389,32%+316,38%+822,07% 22,7 Md
-0,21%+0,84%+16,77%+15,93%+22,71%+22,48%-7,92%-64,24% - 20,23 Md
0,00%+3,00%+11,03%+12,90%-5,87%+27,41%-29,52%-31,91%+57,30% 17,83 Md
-0,97%+0,89%+21,65%+8,98%+29,65%+37,28%+539,62% - - 15,65 Md
-6,69%-5,11%+7,09%+104,10%+163,16%+166,00%+304,89%+1 425,07%+671,10% 15,24 Md
+1,33%-0,38%+2,99%+24,43%+27,55%+25,94%+181,64%+226,17%+524,64% 14,03 Md
-2,56%-2,12%+1,50%+3,58%-8,09%+81,95%+160,43%+503,26%+6 717,96% 12,71 Md
-1,05%+12,77%+4,39%+19,83%+26,58%+418,73%+139,21%+22,91%+1 305,27% 12,05 Md
-2,64%+2,84%+15,25%-30,08%-15,04%-35,61%+134,72%+110,99% - 11,58 Md
-0,59%-1,90%-8,82%+31,11%+25,23%+117,22%+139,30%+173,81%+699,68% 10,95 Md
-4,92%-15,04%-13,20%-41,53%-28,93%-54,72%+486,32%+55,57%+77,44% 10,45 Md
+0,11%+0,02%+127,17%+119,96%+80,27%+176,95%+346,59%+376,25% - 8,84 Md
-2,01%-6,28%+6,75%+40,24%+193,80%+466,84%+568,40%-42,19%-19,96% 8,8 Md
-1,05%+1,19%+21,68%-19,29%+17,71%+26,59%+88,54%+3,61% - 8,72 Md
-4,00%-8,69%+24,48%+27,60%+11,71%+21,00%+315,39%+311,42% - 8,05 Md
+1,06%-4,31%-3,78%-5,43%+20,37%+54,84%+18,93%+139,81% - 8,01 Md
Moyenne -1,09%-0,17%+9,38%+13,15%+25,61%+78,92%+194,67%+186,87%+1 676,33% 17 Md
Moyenne pondérée par Capi. -1,36%+0,90%+7,75%+15,49%+23,33%+64,44%+161,94%+172,94%+2 645,19%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action SPRO
  4. Secteur Spero Therapeutics, Inc.